QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
ETR:GXI

Gerresheimer - GXI Stock Forecast, Price & News

€60.95
+0.95 (+1.58%)
(As of 08/8/2022 12:00 AM ET)
Add
Compare
Today's Range
€59.85
€61.20
50-Day Range
€56.00
€73.50
52-Week Range
€53.45
€92.90
Volume
39,185 shs
Average Volume
140,925 shs
Market Capitalization
$1.91 billion
P/E Ratio
23.26
Dividend Yield
2.08%
Price Target
€93.26
GXI stock logo

About Gerresheimer (ETR:GXI) Stock

Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; miniature bottles and glass containers for liquid food, spices, and spirits; and packaging solutions for fragrances, deodorants, skin care, and wellness products, as well as beauty and pharmaceutical products. The Advanced Technologies division develops smart drug delivery systems, such as micro pumps, which are used to self-administer medication for Parkinson's disease or heart failure to pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.

Receive GXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gerresheimer and its competitors with MarketBeat's FREE daily newsletter.

GXI Stock News Headlines

Gerresheimer presents strong fourth quarter
GERRESHEIMER AG GERRESHEIMER OR (0NTI.IL)
Gerresheimer With Strong Second Quarter
Gerresheimer Ag share price hits a new 52 week high
Gerresheimer Business Model Robust
Gerresheimer Sets Foundation for Profitable Growth in 2019
Gerresheimer AG
Is Gerresheimer AG (ETR:GXI) Trading At A 26% Discount?
See More Headlines
Receive GXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gerresheimer and its competitors with MarketBeat's FREE daily newsletter.

GXI Company Calendar

Today
8/09/2022
Next Earnings (Estimated)
10/12/2022

Industry, Sector and Symbol

Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
10,447
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
€93.26
High Stock Price Forecast
€110.00
Low Stock Price Forecast
€66.30
Forecasted Upside/Downside
+53.0%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.63 billion
Cash Flow
€3.54 per share
Book Value
€36.49 per share

Miscellaneous

Free Float
N/A
Market Cap
$1.91 billion
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Dietmar Siemssen (Age 59)
    CEO of Plastics & Devices and Advanced Technologies Division & Chairman of the Management Board
    Comp: $1.91M
  • Dr. Bernd Metzner Ph.D. (Age 52)
    CFO & Member of the Management Board
    Comp: $1.19M
  • Dr. Lukas Burkhardt (Age 43)
    Member of the Management Board
    Comp: $1.16M
  • Ms. Katja Schnitzler (Age 41)
    Member of Supervisory Board
    Comp: $106k
  • Ms. Carolin Nadilo
    Corp. Director of Investor Relations
  • Ueli Utzinger
    Group Sr. Director Marketing & Communication
  • Mr. Helmut Schweiger
    MD & GM of Gerresheimer Horsovsky Tyn Plant













GXI Stock - Frequently Asked Questions

What is Gerresheimer's stock price forecast for 2022?

0 analysts have issued 1 year price targets for Gerresheimer's stock. Their GXI share price forecasts range from €66.30 to €110.00. On average, they predict the company's share price to reach €93.26 in the next twelve months. This suggests a possible upside of 53.0% from the stock's current price.
View analysts price targets for GXI
or view top-rated stocks among Wall Street analysts.

How has Gerresheimer's stock performed in 2022?

Gerresheimer's stock was trading at €84.70 at the beginning of the year. Since then, GXI shares have decreased by 28.0% and is now trading at €60.95.
View the best growth stocks for 2022 here
.

When is Gerresheimer's next earnings date?

Gerresheimer is scheduled to release its next quarterly earnings announcement on Wednesday, October 12th 2022.
View our GXI earnings forecast
.

Is Gerresheimer a good dividend stock?

Gerresheimer (ETR:GXI) pays an annual dividend of €1.25 per share and currently has a dividend yield of 2.08%. The dividend payout ratio is 47.71%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Gerresheimer own?

What is Gerresheimer's stock symbol?

Gerresheimer trades on the ETR under the ticker symbol "GXI."

What is Gerresheimer's stock price today?

One share of GXI stock can currently be purchased for approximately €60.95.

How much money does Gerresheimer make?

Gerresheimer (ETR:GXI) has a market capitalization of $1.91 billion and generates $1.63 billion in revenue each year.

How many employees does Gerresheimer have?

Gerresheimer employs 10,447 workers across the globe.

How can I contact Gerresheimer?

Gerresheimer's mailing address is Klaus-Bungert-Strasse 4, DUESSELDORF, 40468, Germany. The official website for the company is www.gerresheimer.com. The company can be reached via phone at +49-211-618100.

This page (ETR:GXI) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.